KeyBanc raises IAC stock price target on business simplification By Investing.com

KeyBanc raised IAC/InterActiveCorp’s price target to $51 from $41 while keeping an Overweight rating, implying upside from the current $44.56 share price. The firm cited ongoing simplification efforts, the Care.com sale, and an increased cash position, while also noting aggressive share buybacks and continued shareholder returns. Benchmark separately maintained a Buy rating with a $57 target after IAC finalized the Care.com sale.

Analysis

The market is starting to price IAC less as a collection of optionality and more as a cash-returning simplification story. That matters because once a discount-conglomerate starts shrinking and redistributing capital, the valuation driver shifts from top-line growth to per-share accretion, which can support the stock even if the underlying ad backdrop stays soft. The increased cash balance effectively shortens the path to another round of buybacks, and at this point buyback cadence is more important than operating beats for near-term multiple support.

The main second-order effect is that a cleaner IAC makes the remaining asset base easier to underwrite, which can pull in event-driven capital that normally avoids opaque holding companies. That said, the upside is increasingly sensitive to execution on capital allocation rather than fundamentals, so any pause in repurchases or additional underwhelming asset disposition would likely compress the premium quickly. The market is also likely underestimating how much a weaker ad environment can offset the benefit of simplification over the next 1-2 quarters, making this more of a capital-return trade than a pure operating re-rate.

Consensus appears to be anchoring on liquidation value and ignoring the possibility that IAC’s biggest near-term catalyst is not another sale but a continued reduction in share count. If management keeps retiring stock aggressively, per-share EBITDA and FCF can compound faster than headline segment estimates imply, which supports a higher multiple even with conservative advertising assumptions. Conversely, if the cash gets redeployed into another acquisition rather than returned, the thesis loses its clean, de-risked appeal and the stock could give back much of the recent momentum.

Key Decisions for Investors

• Go long IAC into the next 1-3 months on any pullback toward the low-$40s; risk/reward favors a 10-15% upside move if buyback intensity continues and the market extends the simplification multiple.
• Use Jan-2026 IAC call spreads to express the thesis with defined downside; the trade benefits if the market re-rates the remaining business toward the higher-teens EBITDA multiple implied by bull cases, while limiting exposure if ad spending deteriorates.
• Pair long IAC vs short a higher-beta ad/mid-cap internet basket over the next quarter; the relative trade isolates capital-return upside from macro ad softness and should outperform if execution, not growth, remains the driver.
• Take profits on a rally through the mid-$40s into the prior high until there is evidence of another accretive capital return event; at these levels the stock is increasingly dependent on follow-through rather than new information.
• Monitor for any commentary on post-Care.com cash deployment over the next earnings cycle; if capital is redirected into M&A instead of repurchases, reduce exposure quickly because the market will likely compress the simplification premium.